Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 10,944 |
|
|||||
| News | - |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Lexaria Bioscience Corporation | LEXXW | NASDAQ | Equity Warrant |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.079 | 12.95% | 0.689 | 12:43:53 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.70 | 0.65 | 1.31 | 0.61 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume |
|---|---|---|---|---|
| 190 | 10,944 | 0.9309511 | 10,188 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 12:41:22 | 1 | 0.66 | USD |
Lexaria Bioscience Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 0.00 | - | 464k | -5.8M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Lexaria Bioscience
| Date | Time | Source | Heading |
|---|---|---|---|
| 1/06/2025 | 13:57 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 1/03/2025 | 11:48 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/18/2024 | 12:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/17/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 12/16/2024 | 15:05 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
| 12/05/2024 | 15:56 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 11/26/2024 | 12:01 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 11/14/2024 | 15:11 | Edgar (US Regulatory) | Form SC 13G/A - Statement of Beneficial Ownership by Certain.. |
| 10/18/2024 | 15:42 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/16/2024 | 16:18 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/02/2024 | 11:21 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/23/2024 | 12:28 | Edgar (US Regulatory) | Form SC 13D/A - General Statement of Acquisition of.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
LEXXW Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio. |
NASDAQ:LEXXW -
What is the current Lexaria Bioscience Corporation share price?
The current share price of Lexaria Bioscience Corporation is US$ 0.689
What is the 1 year trading range for Lexaria Bioscience Corporation share price?
Lexaria Bioscience Corporation has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the reporting currency for Lexaria Bioscience Corporation?
Lexaria Bioscience Corporation reports financial results in USD
What is the latest annual turnover for Lexaria Bioscience Corporation?
The latest annual turnover of Lexaria Bioscience Corporation is USD 464k
What is the latest annual profit for Lexaria Bioscience Corporation?
The latest annual profit of Lexaria Bioscience Corporation is USD -5.8M
What is the registered address of Lexaria Bioscience Corporation?
The registered address for Lexaria Bioscience Corporation is 100-740 MCCURDY RD, KELOWNA, BRITISH COLUMBIA, V1X 2P7
What is the Lexaria Bioscience Corporation website address?
The website address for Lexaria Bioscience Corporation is lexariabioscience.com
Which industry sector does Lexaria Bioscience Corporation operate in?
Lexaria Bioscience Corporation operates in the CRUDE PETROLEUM & NATURAL GS sector
